Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Moore

Showing results (251-260 of 354) with videos related to

Pageof 36
Sort By:
Stroke|August 9, 2019
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial FibrillationPatrick Blin, Laurent Fauchier, Caroline Dureau-Pournin, et al.
Pharmacoepidemiology and Drug Safety|December 7, 2007
European commission consultation on pharmacovigilancePatrick Waller, Keith Beard, Toine Egberts, et al.
Food Chemistry|September 8, 2012
Bioavailability of glycitein relatively to other soy isoflavones in healthy young Caucasian menSvitlana Shinkaruk, Marlène Durand, Valérie Lamothe, et al.
Journal of Ethnopharmacology|March 26, 2014
Effect of Cydonia oblonga Mill. leaf extracts or captopril on blood pressure and related biomarkers in renal hypertensive ratsWen-ting Zhou, Adil Abdurahman, Elzira Abdusalam, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 23, 2019
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort studyLaurent Fauchier, Patrick Blin, Frédéric Sacher, et al.
The British Journal of Nutrition|August 7, 2007
Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy malesSébastien Vergne, Catherine Bennetau-Pelissero, Valérie Lamothe, et al.
Targeted Oncology|December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohortAnnie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
Fundamental & Clinical Pharmacology|November 2, 2012
Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratoryStéphane Bouchet, Karine Titier, Nicholas Moore, et al.
Drug Safety|March 20, 2013
Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic riskAlexandre Boyer, Didier Gruson, Stéphane Bouchet, et al.
European Journal of Clinical Pharmacology|March 6, 2014
Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluationFrancesco Salvo, Emanuel Raschi, Ugo Moretti, et al.
Pageof 36

Showing results (251-260 of 354) with videos related to

Sort By:
Pageof 36
Stroke|August 9, 2019
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial FibrillationPatrick Blin, Laurent Fauchier, Caroline Dureau-Pournin, et al.
Pharmacoepidemiology and Drug Safety|December 7, 2007
European commission consultation on pharmacovigilancePatrick Waller, Keith Beard, Toine Egberts, et al.
Food Chemistry|September 8, 2012
Bioavailability of glycitein relatively to other soy isoflavones in healthy young Caucasian menSvitlana Shinkaruk, Marlène Durand, Valérie Lamothe, et al.
Journal of Ethnopharmacology|March 26, 2014
Effect of Cydonia oblonga Mill. leaf extracts or captopril on blood pressure and related biomarkers in renal hypertensive ratsWen-ting Zhou, Adil Abdurahman, Elzira Abdusalam, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 23, 2019
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort studyLaurent Fauchier, Patrick Blin, Frédéric Sacher, et al.
The British Journal of Nutrition|August 7, 2007
Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy malesSébastien Vergne, Catherine Bennetau-Pelissero, Valérie Lamothe, et al.
Targeted Oncology|December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohortAnnie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
Fundamental & Clinical Pharmacology|November 2, 2012
Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratoryStéphane Bouchet, Karine Titier, Nicholas Moore, et al.
Drug Safety|March 20, 2013
Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic riskAlexandre Boyer, Didier Gruson, Stéphane Bouchet, et al.
European Journal of Clinical Pharmacology|March 6, 2014
Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluationFrancesco Salvo, Emanuel Raschi, Ugo Moretti, et al.
Pageof 36